VIDEO: Luspatercept shows promising improvement in myelofibrosis anemia
Click Here to Manage Email Alerts
In this video, Idoroenyi Amanam, MD, discussed a study presented at ASCO Annual Meeting, examining the use of luspatercept in the treatment of anemia in myelofibrosis patients.
Amanam, an assistant professor in the Division of Leukemia at City of Hope Cancer Center, highlighted a study which examined four cohorts of patients and found that the patients with the best anemia responses were transfusion-dependent and on ruxolitinib (Jakafi, Incyte).
“In a space that we don’t have too many options, I think this is great,” Amanam said. “You can use this in patients who are or aren’t on ruxolitinib, and everyone should be able to receive luspatercept [Reblozyl; Celgene, Bristol Myers Squibb] if you’re anemic.”
Collapse
Read more about
Click Here to Manage Email Alerts